WHO grants Emergency Use Listing to BioFire’s Global Fever Special Pathogens Panel, enabling rapid detection of Ebola and 15 ...

Ultima Genomics’ UG200 Platform will support an 80,000-sample UK Biobank immune profiling study with IMU Biosciences.

Biodesix and Vanderbilt are developing an AI-driven lung cancer risk test combining blood-based and imaging biomarkers.

Diadem receives a US patent expanding protection for its AlzoSure Predict blood assay, which detects U-p53AZ, a biomarker ...

A Penn State-led team developed a rapid syphilis test that detects low antibody titers in one step, with up to 46% stronger ...

Delve Bio launched Delve Detect Plasma, a blood-based mNGS assay that detects over 68,000 pathogens with next-day results, ...

A peer-reviewed study validates Gnosis' EdenDx cervical sample test, showing 96.8% specificity for endometrial cancer ...

The companies will collaborate with AstraZeneca to advance local lab testing for a prostate cancer genomic instability ...

New studies presented at ACG 2026 indicate TissueCypher offers objective risk assessment for Barrett’s esophagus progression ...

Labcorp to acquire select BioReference Health assets from OPKO Health for $722 million, including labs, service centers, and ...

Biodesix is presenting data showing Nodify Lung assay’s integration with PET imaging and its impact on lung nodule diagnostic ...

Modeling presented at ACG 2026 shows Guardant Health’s blood-based colorectal cancer screening averts more deaths and ...